Clinical Trials in San Juan, Puerto Rico
7 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 3
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Non-small Cell Lung CancerNSCLCNSCLC (Advanced Non-small Cell Lung Cancer)+2 more
Revolution Medicines, Inc.420 enrolled129 locationsNCT06881784
Recruiting
Phase 3
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
Follicular Lymphoma ( FL)
Genmab1,095 enrolled265 locationsNCT06191744
Recruiting
Phase 3
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Pancreatic CancerPDACPDAC - Pancreatic Ductal Adenocarcinoma+2 more
Revolution Medicines, Inc.500 enrolled7 locationsNCT07252232
Recruiting
Not Applicable
Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
Diabetes Mellitus, Type 2
Stanford University119,680 enrolled4 locationsNCT06251323
Recruiting
Not Applicable
The Puerto Rico Asthma Integrated Response Program ("PR-AIR")
Pediatric Asthma
Rhode Island Hospital480 enrolled2 locationsNCT05999032
Recruiting
Phase 1
Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC
SCLC,Extensive Stage
RayzeBio, Inc.49 enrolled15 locationsNCT05595460
Recruiting
Not Applicable
Building Resilience at Schools: Emotional and Biological Assessment and Treatment of Traumatic Stress
StressMental Health IssuePost Traumatic Stress Disorder+2 more
Stanford University80,800 enrolled3 locationsNCT05701111